Effect of infliximab on threatening panuveitis in Behçet's disease.
Muñoz-Fernández
S
S
Hidalgo
V
V
Fernández-Melón
J
J
Schlincker
A
A
Martín-Mola
E
E
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D015864:Panuveitis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab